Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

July 01, 2014

In Genetic Haystacks, We’re All Needles

According to Sharon Terry, as we scrutinize diseases at an ever more granular level, we will find that whatever disease a person has, it’s highly likely to be a “rare” disease.

In Genetic Haystacks, We’re All Needles

Sharon Terry is president and CEO of Genetic Alliance.

The task of finding and recruiting sufficiently large cohorts for studying genetic diseases has up to now been a needle in the haystack problem This is rapidly changing as Sharon F Terry and her colleagues at Genetic Alliance are making possible aggregation of individual health information in ways and on ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content